Integrated two-way ANOVA and ASCA analysis of key prognostic and temporal metabolite changes. This table summarizes metabolites with significant abundance differences (p < 0.05) identified by both two-way ANOVA (F > 2.5) and ASCA (significant leverage/SPE ratio). Metabolites are categorized by prognosis, sampling time, and their interaction. Creatine and tyrosine (*), significant in both analyses, are highlighted as key markers distinguishing prognostic groups (HD, PS, and Exitus).
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接：
官方服务：
资源简介：
Integrated two-way ANOVA and ASCA analysis of key prognostic and temporal metabolite changes. This table summarizes metabolites with significant abundance differences (p < 0.05) identified by both two-way ANOVA (F > 2.5) and ASCA (significant leverage/SPE ratio). Metabolites are categorized by prognosis, sampling time, and their interaction. Creatine and tyrosine (*), significant in both analyses, are highlighted as key markers distinguishing prognostic groups (HD, PS, and Exitus).
创建时间：
2025-07-03
